Inhibition of nuclear factor-κB activation is essential for membrane-associated TNF-α-induced apoptosis in HL-60 cells

Immunology and Cell Biology

Volumn 84, Issue 4, 2006, Pages 366-373

  Shi, Wenfang ^a   Li, Lingyun ^a   Shi, Xu ^a   Zheng, Fang ^a   Zeng, Jingyang ^a   Jiang, Xiaodan ^a   Gong, Feili ^a   Zhou, Muxiang ^b   Li, Zhuoya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Membrane bound form of TNF (mTNF ); Nuclear factor kappa B (NF B); Soluble TNF (sTNF ); TNF receptor associated factor 1 (TRAF1); TRAF2

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MOLECULE; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CELL MEMBRANE; CYTOPLASM; HL-60 CELLS; HUMANS; I-KAPPA B PROTEINS; MICE; NF-KAPPA B; NIH 3T3 CELLS; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33745057774     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2006.01436.x     Document Type: Article

References (38)

1. Krigler M. A novel form of TNF/cachethin is a cell surface cytotoxic transmembrane protein: remification for the complex physiology of TNF. Cell 1988 53 : 45 53.
2. Luettig B Decker T Lohmann-Matthes ML. Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J. Immunol. 1989 143 : 4034 8.
3. Peck R Brockhaus M Frey JR. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell. Immunol. 1989 122 : 1 10.
4. Peck R Brockhaus M Frey JR. The principal tumor necrosis factor receptor in monocyte cytotoxicity is on the effector cell, not on the target cell. Cell. Immunol. 1991 132 : 308 18.
5. Shi WF Li ZY Gong FL. Comparison of cytotoxicity by transmembrane and secretory TNF-α. Chin. J. Microbiol. Immunol. 1998 18 : 9 13.
6. Tartaglia LA Weber RF Figari IS Reynolds C Palladino MA Jr. Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl Acad. Sci. USA 1991 88 : 9292 6.
7. Grell M Douni E Wajant H et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995 83 : 793 802.
8. Reid TR. Mechanism of tumor necrosis factor cytotoxicity and cytotoxic signal transduced by the p75-tumor necrosis factor receptor. J. Biol. Chem. 1994 269 : 14 459 64.
9. Renu AH. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992 70 : 47 56.
10. Kuroki J. Cell permeable ceramide inhibits the growth of B lymphoma cell lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis. Leukemia 1996 10 : 2711 14.
11. Chen G Goeddel V. TNFR1 signaling: a beautiful pathway. Science 2002 296 : 1634 5.
12. Micheau O Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003 114 : 181 90.
13. Rothe M Sarma V Dixit VM Goeddel DV. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995 269 : 1424 7.
14. Barnes PJ Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997 336 : 1066 71.
15. Wang CY Mayo MW Korneluk RG Goeddel DV Baldwin AS Jr.. NFkB antiapoptosis: induction of TRAF1 and TRAF2 and cIAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998 281 : 1680 3.
16. Chu ZL McKinsey TA Liu L Gentry JJ Malim MH Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kB control. Proc. Natl Acad. Sci. USA 1997 94 : 10 057 62.
17. Stehlik C de Martin R Kumabashiri I Schmid JA Binder BR Lipp J. Nuclear factor (NF)-kB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med. 1998 188 : 211 16.
18. Cheng Q Lee HH Li Y Parks TP Cheng G. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition. Oncogene 2000 19 : 4936 40.
19. Wang CY Guttridge DC Mayo MW Baldwin AS Jr.. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 1999 19 : 5923 9.
20. Beg AA Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996 274 : 782 4.
21. van Antwerp DJ Martin SJ Kafri T Green DR Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996 274 : 787 9.
22. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 2001 107 : 241 6.
23. Arron JR Pewzner-Jung Y Walsh MC Kobayashi T Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF) 2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 2002 196 : 923 34.
24. Abe Y Gatanaga M Osuka Y et al. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J. Immunol. 1993 150 : 5070 9.
25. Higuchi M Aggarwal BB. Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J Immunol. 1994 152 : 4017 25.
26. Beg AA Sha WC Bronson RT Ghosh S Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995 376 : 167 70.
27. Nguyen LT Duncan GS Mirtsos C et al. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 1999 11 : 379 89.
28. Yeh WC Shahinian A Speiser D et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997 7 : 715 25.
29. Chung JY Park YC Ye H Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell. Sci. 2002 115 : 679 88.
30. Carpentier I Beyaert R. TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett. 1999 460 : 246 50.
31. Henkler F Baumann B Fotin-Mleczek M et al. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. J. Biol. Chem. 2003 278 : 29 216 30.
32. Fries KL Miller WE Raab-Traub N. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology 1999 264 : 159 66.
33. Zapata JM Reed JC. TRAF1: lord without a RING. Sci. STKE 2002 2002: PE 27.
34. Park YC Burkitt V Villa AR Tong L Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999 398 : 533 8.
35. Ansieau S Scheffrahn I Mosialos G et al. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc. Natl Acad. Sci. USA 1996 93 : 14 053 8.
36. Wang CY Mayo MW Korneluk RG Goeddel DV Baldwin AS Jr.. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998 281 : 1680 3.
37. Fotin-Mleczek M Henkler F Hausser A et al. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. J. Biol. Chem. 2004 279 : 677 85.
38. Conti A Ageunnouz M La Torre D et al. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas. J. Neurosurg. 2005 103 : 873 81.